Condensed Statement of Shareholders' Deficiency - USD ($)	3 Months Ended
	Apr. 30, 2020	Apr. 30, 2019
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance (in shares)	1,233,853
Beginning Balance	$ (745,020)	$ (678,551)
Net loss	$ (20,417)	(18,641)
Ending Balance (in shares)	1,233,853
Ending Balance	$ (765,437)	$ (697,192)
Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance (in shares)	1,233,853	1,233,853
Beginning Balance	$ 1,233	$ 1,233
Ending Balance (in shares)	1,233,853	1,233,853
Ending Balance	$ 1,233	$ 1,233
Additional Paid-in Capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance	81,323	81,323
Ending Balance	81,323	81,323
Accumulated Deficit
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance	(827,576)	(761,107)
Net loss	(20,417)	(18,641)
Ending Balance	$ (847,993)	$ (779,748)